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Available online 15 November 2011Abstract Tissue resident mesenchymal stem cells (MSCs) are known to participate in tissue regeneration that follows cell
turnover, apoptosis, or necrosis. It has been long known that aging impedes an organism's repair/regeneration capabilities.
In order to study the age associated changes, the molecular characteristics of adipose tissue derived MSCs (ASCs) from
three age groups of healthy volunteers i.e., young, middle aged, and aged were investigated. The number and multilineage
differentiation potential of ASCs declined with age. Aging reduces the proliferative capacity along with increases in cellular
senescence. A significant increase in quiescence of G2 and S phase was observed in ASCs from aged donors. The expression
of genes related to senescence such as CHEK1 and cyclin-dependent kinase inhibitor p16ink4a was increased with age,
however genes of apoptosis were downregulated. Further, an age-dependent abnormality in the expression of DNA
break repair genes was observed. Global microRNA analysis revealed an abnormal expression of mir-27b, mir-106a,
mir-199a, and let-7. In ubiquitously distributed adipose tissue (and ASCs), aging brings about important alterations,
which might be critical for tissue regeneration and homeostasis. Our findings therefore provide a better understanding
of the mechanism(s) involved in stem cell aging and regenerative potential, and this in turn may affect tissue repair
that declines with aging.
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Aging is an intricate process characterized by a variety of
disorders associated with generalized decline and inability
to maintain tissue homeostasis. Throughout life, stem cells
persist in numerous tissues replacing mature cells lost during
physical activity or injury. However, the function of stem
cells and other progenitors decline with age (Maslov et al.,
2004), consequently aging tissues demonstrate decreased
repair capacity and increased preponderance for degenerative
disorders (Campisi, 2005). To date, the role of stem cells in
aging, more specifically, mechanisms responsible for age-
related decline in function of stem/progenitor cells is
hotly debated. Tissue resident stem cells or mesenchymal
stem cells (MSCs) are ubiquitously distributed and have
specifically been characterized in tissues including bone
marrow, adipose, skeletal muscle, dermis, and umbilical
cord (Tuan et al., 2003). Morphologically and immuno-
phenotypically, no significant differences have been observed
among the MSCs regardless of tissue origin (Docheva et al.,
2007; Izadpanah et al., 2006). Age-related decline in the quan-
tity of MSCs in bone marrow has been reported in rodents,
monkeys, and humans (Lee et al., 2006a; Mareschi et al.,
2006; Yue et al., 2005). These studies, however, focused on
the effect of aging on reduction of differentiation properties
of bone marrow derived MSCs (Karagiannides et al., 2001;
Tokalov et al., 2007; Zheng et al., 2007). We and others
have reported the impact of prolonged in vitro expansion of
two types of adult MSCs, bone marrow and adipose tissue
derived MSCs (ASCs), and have provided some insight into
the probable age-related decline in self-renewal and dif-
ferentiation potential of MSCs (Izadpanah et al., 2008). It
has recently been shown that proliferation potential decreased
in aged ASCs compared to young ASCs (Efimenko et al., 2011),
which ultimately causes accumulation of non-replicative ASCs
and have been associated with caloric restriction (Schmuck
et al., 2011). It is also shown that aging alters the availability
of adipose tissue-derived CD45−/CD34+/CD133+ cells and
their angiogenic function (Madonna et al., 2011). However,
there are claims that age does not seem to affect ASC viability
and in vitro adipogenic differentiation significantly, whereas it
does affect osteogenic differentiation (de Girolamo et al.,
2009). Furthermore, as to what mechanisms for self-renewal
and differentiation underlie the process of aging, and the
effects on the biology of cell growth, cell cycle, and pro-
mote cell senescence and apoptosis in MSCs are not well
understood.
The genetic and epigenetic alterations responsible for aging
of stem cell are reported, and include changes that directly
affect cell cycle, genetic stability, and DNA damage and repair
(Marasa et al., 2010). Considerable effort has been made
toward identifying the role of microRNAs (miRNA) in regulating
the aging process. miRNAs are 19–25 nucleotides in length,
which bind to a 3′ un-translated region (3′UTR) of an RNA tran-
script in a complimentary and sequence-specific manner
resulting in antagonizing the translational efficiency of the
transcript (Bartel, 2009). Evidence suggests that miRNAs are
important regulators of a variety of cellular processes including
cell survival, proliferation, differentiation, and senescence
(Bartel, 2009; Ambros, 2004). Further, with model organisms,
change in the expression patterns of miRNA during a cell's life-
span and existence of variations in their expression that maydirectly affect the aging process are reported (Bates et al.,
2010; Li et al., 2009).
In the present report, we characterized several age-
related alterations in ASCs. Using ASCs from healthy young,
middle aged, and aged volunteers (Groups 1, 2, and 3, respec-
tively) we demonstrate a significant decrease in the cell num-
ber concomitant with the volunteer age paralleled by
increased population doubling time and cell senescence. We
also profiled miRNA expression in both young and aged individ-
uals and identified miRNAs that are differentially expressed in
aged volunteers. The observations from our studies indicate
that various molecular, genetic and epigenetic alterations
take place in ASCs during the progression of age. These changes
impact on proliferation and differentiation potential of tis-
sue resident stem cells, and ultimately affect the tissue ho-
meostasis and repair capabilities.
Results
Characterization of ASC properties in different age
groups
ASCs isolated from the age Groups 1, 2, and 3 exhibit identical
characteristics such as expression of CD44, CD90, CD105, and
CD146 and absence of surface markers CD3, CD4, CD11b,
CD34, and CD45, respectively. In order to assess the number
of growing adherent cells/g of adipose tissue and evaluate
their ability to form colony, equal number of cells were plated
after processing the tissue and the number of individual cells
and colonies were recorded on days 5 and 8. There was a
decrease in the number of single cells from day 5 to day
8 in all three groups with group 1 showing the highest number
of single adherent cells in culture on day 5 (421/cm2 of cul-
ture area). This number decreased greatly concurrent with
increased number of colonies by day 8 (24/cm2) indicating
that these cells were able to form colonies. Group 2 cells
also showed a similar decrease in the number of growing
cells by day 8, but the absolute decrease in count was
lower than Group 1 (358/cm2, day 5 to 135/cm2, day 8).
Compared to Groups 1 and 2, ASCs from Group 3 showed a
lower cell (single) count on day 5 (89/cm2), which decreased
by day 8 to 21/cm2, the decrease however was not as seen in
Group 1 or 2 (Fig. 1). The number of colonies increased from
day 5 to day 8 in all three groups. The number of colonies was
comparable between Groups 1 and 2, however, these cells
formed larger colonies which merged rapidly while cells of
Group 3 could only form smaller size colonies with limited
number of cells.
The cumulative population doublings of ASCs were quanti-
fied in all three groups. Compared toGroup 1, Group 3 exhibited
a significant increase (about 38%) in population time (Fig. 2A).
Simultaneously, colony forming unit (CFU) potential of ASCs de-
clined by about 30% in Group 3 compared to Group 1 (Pb0.01)
indicating that as age advances the number of ASCs that are ca-
pable of replicating and form colonies decrease (Fig. 2B).
For all three groups, the cell cycle distribution of ASCs
was determined by FACS analysis following propidium iodide
staining of cellular DNA. An assessment of the percentage of
cells in G1, S, and G2-M phases among the ASCs of Groups 1
and 3 indicated a slight decrease in the number of cells in
the quiescent G1 phase of the cell cycle (Fig. 3A). However,
Figure 1 Aging decreases the number of ASCs. Graph represent-
ing counts of adherent single cells and colonies obtained from 50 g
of adipose tissue specimens upon processing of tissue for isolation
of ASCs in three groups (i.e., Group 1, Group 2, and Group 3).
The single cells and colonies from each culture were counted
from 20-microscope fields on days 5 and 8 following processing
tissue samples. The graphs are made from triplicate experiments
on at least 8 volunteers per group (Pb0.05; *Pb0.01).
217Aging alters tissue resident mesenchymal stem cell propertiesthere was a significant increase in the G2 phase and decrease
in the S phase (n=15; Pb0.05) (Figs. 3B and C). The increased
G2 phase arrest was coupled with decreased G1 and S phase
entry in ASCs of Group 3. Using real time RT-PCR, a transcrip-
tome analysis of ASCs from all three groups was performed to
obtain an overview of genes associated with regulation of
cell cycle. A significant up-regulation of genes that promote
a G2 phase arrest such as CHEK1 (4.4 folds) was observed and
most significantly a 22.9 fold increase of p16INK4a (related to S
phase entry prevention) was detected. The expression of ATM,
E2F transcription factor 4 (E2F4), retinoblastoma 1 (RB1),
BRCA1, and HMGA2 — that play a crucial role in the control
of a cell cycle were marginally upregulated in Group 3 com-
pared to Group 1 (Fig. 3D).0 
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Figure 2 Age-associated decline in ASC's replication capacity. AS
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density of 25 cells=cm2 for 10 days in culture, stained with 1% crystAnalysis of genes involved in apoptosis and DNA repair
Real time RT-PCR analysis revealed a significant change in the
transcripts encoding apoptotic regulators such as ATR (2.6±
0.9 folds), TNFα (5±1.4 folds), and NFκB (4±0.4 folds).
However, the expression of hTERT transcript, p53, and caspase
family genes including Casp3, Casp8, and Casp9 decreased in
Group 3. In addition, the expression of anti-apoptotic genes
BCL2 and BAX was upregulated whereas the expression of
BIRC5 (survivin) was downregulated in Group 3 (Fig. 4A).
A dramatic reduction of telomerase activity in Group 3
ASCs was also observed (Fig. 4B).
Since it is known that during the aging process there is an
accumulation of DNA replication errors and mutations, the
DNA repair among three groups was analyzed. The RT-PCR
analysis for the expression of genes involved in the process
of cellular DNA repair revealed an up-regulation of XRCC4
(3±1.1 folds) and XRCC6 (4.8±0.4 folds) in ASCs of Group 3
compared to Group 1. However, there was a marginal down-
regulation of APEX1 (1.15±0.4 folds; n=5) in ASCs from
Group 3 compared to Group 1 (Fig. 4C). The comet assay
was then used to evaluate the DNA damage; cells from
Group 3 showed a small increase in comet tail (Fig. 4D).
To examine the spontaneous tumorigenic potential of
ASCs from different age groups, ASCs from all three groups
were subcutaneously injected into the flank of immune defi-
cient mice (n=9 per group). No tumors were found in any of
the SC populations even after 120 days. In line with this by
PCR assay human Alu sequence was not detected in liver,
lung, and kidney of these mice.Age-related decline of multi-lineage differentiation
potential in SC
In order to study multilineage differentiation capacity of
ASCs from all three groups, cells were differentiated toward
the adipogenic, osteogenic, and chondrogenic lineages using0% 
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Figure 3 Cell cycle characteristics of aging ASCs. Mitotic indices of ASCs from Groups 1 and 3. Graphs in A, B, and C represent DNA
content indicating the percentages of cells in G1, S, and G2 phases of the cell cycle. The data are obtained from staining the DNA of
ASCs from Groups 1 and 3 (passage 1–5). Both ASC types showed diploid phenotype. A decrease in percentage of cells in G1 and S
phases was seen in Group 3 (A and C). B) These cells showed a greater fraction in quiescent of G2 phase. Real time RT PCR analysis
of cell cycle associated gene expression among the three groups. The bar graphs show the gene expression from Groups 2 and 3
compared to Group 1 (n=5 volunteers/group, Pb0.05; *Pb0.01). All values were normalized to ASCs from Group 1.
218 E.U. Alt et al.lineage-specific induction factors. The percentage of cells
capable of undergoing adipogenic differentiation declined
from about 33% in Group 1 to about 10% in Group 3 (Fig. 5A).
Real time RT-RCR analysis on lineage specific transcriptomes
indicated a down-regulation of LPL (7.9±1.2 folds) and CEBPA
(4.53±2.7 folds) in Group 3 compared to Group 1 (Fig. 5B).
Osteogenic differentiation potential was found to decline
significantly with progression of age. In addition to differences
in staining for calcium deposits in differentiated cultures, ALP
concentration, representative of the level of osteogenic dif-
ferentiation activity in Group 3 was markedly reduced when
compared to Group 1 (from about 50% in Group 1 to about 22%
in Group 3; n=5/group) (Fig. 5C). Accordingly, it was inferred
that the chondrogenic potential as well decreased with aging.
Analysis of the expression of lineage specific markers revealed
a down-regulation of BMP6 (2.8±0.8 folds), COL2A (3±0.4
folds), and Col10A (2.9±1.2 folds; Pb0.05) genes in ASCs from
Group 3 compared to Group 1 (Fig. 5D).microRNA analysis
To determine the extent to which microRNAs (miRNA) con-
tribute to age-related changes in gene expression of ASCs,
the miRNA of ASCs from Groups 1 and 3 were profiled usinga miRNA microarray platform that probes for 911 mature
human miRNAs and 148 viral miRNAs. Microarray results
identified miRNAs with change in expression in Group 3 by
more than 1 SD compared to the mean expression of each
miRNA in Group 1. The results of this microarray analysis sug-
gest that there was a subnormal expression of several miRNAs
regulating cell cycle, apoptosis and multilineage potential of
stem cells in Group 3. There was substantial downregulation
of miRNA implying progression of apoptosis and inhibition
of differentiation potential of stem cells including mir-27B
and let-7G (Fig. 6A). We further examined the expression
of several miRNAs among the three groups with quantita-
tive real-time RT-PCR. The miRNAs were selected on the
basis of microarray results. These results demonstrated an
identical pattern of downregulation for Let7g (3.95±0.2
folds), mir-27B (3.43±0.7 folds), mir-106a (0.94±0.3 folds),
and mir-199a (4.68±0.6 folds; Pb0.05, n=5/group) in Group
3 compared to Group 1 (Fig. 6B).Discussion
The results of our study clearly demonstrate a correlation
between age-related decrease in the quantity of tissue resi-
dent stem cells, and their impairment in self-renewal and
A B
DC
Figure 4 Aging causes transcriptomic alterations in apoptotic and DNA break repair genes. Real time RT-PCR analysis of genes associ-
ated to apoptosis (A) and DNA repair (C). All values were normalized to ASCs from Group 1 in three independent experiments (n=5 vol-
unteers/group; Pb0.05; *Pb0.01). B) The telomerase activity measured using TRAP ELISA kit showed a marked decrease activity in
Group 3 ASCs. D) The comet formation in different age groups was assessed three cultures were prepared in parallel. Bars indicate
means±SD results (Pb0.05) obtained with three slides/Group (per slide 50 cells were evaluated).
219Aging alters tissue resident mesenchymal stem cell propertiesdifferentiation capabilities. While equal amounts of tissue
samples were analyzed, there was a substantial reduction
in the quantity of available resident stem cells in Group 3.
In addition, compared to Groups 1 and 2, only a limited number
of ASCs from Group 3 were capable of forming colonies. A
weaker CFU ability and increased population doubling time
were observed in Groups 2 and 3 compared to Group 1. Some
studies on bone marrow derived MSCs have shown a link
between aging and declined self-renewal capacity of cells
(Kasper et al., 2009; Wagner et al., 2010a). Interestingly,
it is reported that these changes in stem cells are accom-
panied by an abnormal cell cycle profile. Our data show
an increase in G2 phase and S phase profiles in ASCs from
Groups 2 and 3. Additionally, pathways that regulate cell
cycle comprising of p16INK4a and cell cycle check point kinase
genes were perturbed in Group 3. Previous studies have
shown that p16INK4a gene expression increases with age in
various tissues (Zindy et al., 1997; Krishnamurthy et al.,
2006). Although induction of p16INK4a expression can cause
senescence in a variety of cell types in vitro and in vivo
(Sharpless et al., 2004; Michaloglou et al., 2005), some
progenitor cells are reported to be unaffected by increase
in p16INK4a expression or p16INK4a deletion (Molofsky et al.,2005). The novelty of our findings is the demonstration of a
significant increase in expression of p16INK4a in ASCs from
Group 3. Although, there was an increase in the expression
of CHEK1, other cell cycle regulators such as ATM, E2F4,
HMGA2, RB1, and BRCA1 displayed only a marginal increase
in Group 3 (Fig. 3D). Our data also show a downregulation
of genes associated with apoptosis such as p53, caspase 3,
caspase 8, and caspase 9 in Group 3. The report of an age-
associated decline in the expression of p53 in bone marrow
derived SCs (Wilson et al., 2010) support our findings. Simul-
taneously the expression of anti apoptotic gene BCL2 was sig-
nificantly upregulated in ASCs from Group 3. Danial and
Korsmeyer have reported that overexpression of BCL2 is asso-
ciated with enhancement of the survival of many cell types
(Danial and Korsmeyer, 2004). Furthermore, in ASCs from
Group 3, there was a significant upregulation of NFκB, TNFα
and the genes for their corresponding receptors. There are
reports suggesting that NFκB can be activated by TNFα
(Krappmann and Scheidereit, 2005) and engage in the survival
pathway by upregulating BCL2 (Li et al., 2002).
An analysis of the expression of apoptosis factors such as
p53 and senescence markers including p16INK4a indicates
that age-associated decline in ASC proliferation might mainly
A C
B D
Figure 5 Effect of aging on the differentiation potential of ASCs. A) Percentage of positively stained adipogenic differentiated cells of
the three group ASC cultures. Cells were incubated in adipogenic induction medium for 12 days and stained with Oil Red O, and ab-
solute cell numbers were counted (n=5; Pb0.05). B) Real time RT PCR analysis of genes in adipogenic differentiated cells. All values
were normalized to adipogenic differentiated ASCs from Group 1 (x-axis). C) Levels of alkaline phosphatase in ASCs from the three
groups following incubating of cells in the osteogenesis induction medium for 12 days (n=5). Real time RT PCR analysis of genes in chon-
drogenic differentiated ASCs from Groups 2 and 3 compared to Group 1 (n=5; Pb0.05).
220 E.U. Alt et al.be controlled by senescence pathways. In the absence of abnor-
mal environmental factors, the importance of p16INK4a and p53
in tumor suppression indicates that these genes are utilized
frequently throughout life and the cancer incidence is indica-
tive of their failure (Ruzankina and Brown, 2007). Although
p16INK4a and p53 play an anti-oncogenic role, constant acti-
vation of these genes can result in accumulation of senes-
cent/apoptotic cells which, in turn, influence tissue
homeostasis and slow down tissue renewal capacity and
thus promote aging. ASCs from different age groups were
not able to form any detectable tumor up to 120 days even
in our studies.
Further, the expression of hTERT and telomerase activity
decreased significantly in ASCs from aged volunteers. These
findings are in agreement with existing data indicating that
telomere dysfunction contributes to aging in human stem
cells (Rudolph et al., 1999). In the absence of adequate
telomerase activity, telomere shortening occurs. Animal
models with abnormal telomere function have been shown
to develop features of premature aging related to senescence
and apoptotic mechanisms (Rudolph et al., 1999; Allsopp et
al., 2003). Bazarov et al. have shown the suppressive effects
of p16INK4a on hTERT (Bazarov et al., 2010). Recent studies on
hematopoietic stem cells, neuronal stem cells, and pancreat-
ic islet cells have shown that increasing levels of p16INK4awere not only associated with aging but partly contribute to
age-induced replicative failure (Krishnamurthy et al., 2006;
Janzen et al., 2006; Molofsky et al., 2006).
In addition to abnormal expression of cell cycle genes, an
irregular expression of genes involved in DNA break repair
such as APEX, XRCC4 and XRCC6 was observed with the pro-
gression of age. Age associated downregulation of APEX has
been shown in male germ line cells (Allen et al., 2008). Sim-
ilar to this, we observed a decrease in the expression of APEX
in ASCs from Group 3. The irregular expression of DNA repair
genes and higher comet tail indicate a higher DNA damage
and possible repair activity.
Our data signify that aging processes have drastic effects on
the differentiation potential of ASCs. We found a considerable
decline in differentiation capacity of ASCs from Group 3. Com-
pared to Group 1, the Group 3 cells displayed a significantly
lower osteogenic, adipogenic, and chondrogenic differentiation
potential. The decline in differentiation potential could be con-
sidered as one of the consequences of abnormal self-renewal in
ASCs.
miRNA profiling among cells from Groups 1 and 3 revealed
significant downregulation of a limited number of miRNAs in
ASCs from Group 3 including mir-27b, mir-106a, mir-199a,
and let-7, while the majority remained unchanged in aged
ASCs. Downregulation of mir-27b has been shown to have
AB
Figure 6 Effects of aging on ASC's miRNA expression. A) RNA
extracted from ASCs of Groups 1 and 3 was used for microarray
analysis of differential expression of miRNAs in ASCs. Fold
change was calculated in Group 3 compared to Group 1
(Pb0.05). B) Quantitative real-time PCR of miRNAs performed
to validate the microarray data. Down-regulation of mir-27b,
mir-199a, mir-106a, and Let7g in microarray experiments was
validated by quantitative PCR analysis (*Pb0.01).miRNA expression
values were normalized to three constitutive miRNA references u6,
5s, snord44 (n=7 volunteers/group; Pb0.05).
221Aging alters tissue resident mesenchymal stem cell propertiesan important effect in cellular aging, and is considered to
be specifically crucial in the regulation of development,
growth, and/or differentiation of multiple lineages of he-
matopoietic stem cells and muscle stem cells (Feng et
al., 2009; Crist et al., 2009). Both lin-28 and let-7 were
discovered in Caenorhabditis elegans as heterochronic regu-
lator of larval and vulval development and have recently
been implicated in cancer, stem cell aging and pluripotency.
Particularly, let-7 targets Myc, Kras, Igf2bp1 and Hmga2
which are known regulators of metabolism and body size
(Zhu et al., 2010). It has also been reported that let-7 may
be involved in regulating transcription in response to prolif-
erative signals (Gu and Iyer, 2006). Also, let-7 directly tar-
gets and represses IL-6, which is inhibited by NFκB and
therefore may be involved in a positive feedback loop
(Iliopoulos et al., 2009). Additionally, studies on endothelial
cells, replicated CD8+ T cells, renal proximal tubular epithelial
cells, and skin fibroblasts revealed a downregulation of mir-
106a together with the downregulation of mir-19b, mir-20a,
and mir-17. This has been correlated to increased transcriptlevels of some established target genes, particularly CDK
inhibitor p21/CDKN1A in replicative cell aging models
(Hackl et al., 2010). However, our data with ASCs did not
show any significant downregulation of mir-19b, mir-20a,
and mir-17 in Group 3. There is compelling evidence indi-
cating direct involvement of miR-199a in chondrogenic and os-
teogenic differentiation (Lin et al., 2009). miR-199a has also
been reported to directly target SIRT1 (Rane et al., 2009).
SIRT1, a mammalian homologue of silent information regula-
tor 2 has been shown to promote longevity in yeast and mam-
malian cells (Kaeberlein et al., 1999). SIRT1 deacetylates a
large number of substrates, including p53, XRCC6, NFκB, and
forkhead proteins, and has been reported to affect various
physiological processes (Chen et al., 2010). These findings
demonstrate that with advancement of age, miRNAs could pos-
sibly be playing a role in the aging of ASCs. The loss of miRNA
function during the aging process may be due to transcrip-
tional repression, deletion, mutation, epigenetic silencing,
or aberrant miRNA processing (Liang et al., 2009). The age-
associated decrease in miRNA abundance and its probable
role in the normal functioning of tissue resident stem cells
as presently reported is an important and novel finding
that warrants additional investigations.
We and others have shown the effect of prolonged in vitro
replication (in vitro aging) potential of ASCs (Izadpanah et
al., 2008; Wagner et al., 2010b). One of the most significant
outcomes of in vitro aging in ASCs was the increase in cell se-
nescence and apoptosis. This was also accompanied by the
increased expression of DNA repair genes, indicative of
more DNA break probabilities. In addition, ASCs from Group
3 showed subnormal cell cycle and miRNA expression. Most
importantly, despite all the reported changes in the cells no
tumorigenicity was observed in immunodeficient mice.
Considering abundant and ubiquitous distribution of adipose
tissue in the body, resident ASCs may play a significant role in
normal growth and homeostasis and can be considered as vital
components of tissue repair. Recently, in ASCs derived from di-
abetic donors we reported the existence of similar characteris-
tics such as self-renewal and differentiation potential.
Interestingly, in the present study, we observed some cellu-
lar events in ASCs from volunteers of aged group that were
similar to those seen in ASCs from diabetic donors
(Cramer et al., 2010). Importantly, in the present investiga-
tion, ASCs were obtained only from non-diabetic healthy vol-
unteers. We are therefore tempted to suggest that both
aging and diabetes result in impairment of tissue repair
mechanisms as tissue repair is a stem cell mediated pro-
cess. It is also plausible to speculate that the impairments
of tissue repair are accelerated when there is an association
of aging and diabetes.Conclusions
In summary, for the first time using ASCs from young, middle
age, and aged healthy volunteers, the effect of aging on the
self-renewal and differentiation potential of ASCs is presented.
Further, ASCs, the residing stem/progenitor cells (within the
abundantly distributed adipose tissue) are likely play a signifi-
cant role in tissue repair and homeostasis. This would then sug-
gest that an impairment of these cells due to the process of
aging could be responsible for the underlying mechanisms of
222 E.U. Alt et al.aging and related disorders. In conclusion, our findings may
help in the useful application of ASCs as therapeutic options,
especially for tissue repair in the elderly.
Materials and methods
Isolation and expansion of ASCs
The volunteers or their legal guardians were consented
based on the approved protocol by the Institutional Review
Board (IRB) of the Tulane University Health Sciences Center.
Healthy volunteers between 15 and 71 years of age were
grouped into three groups comprising of Group 1 (b20 years;
n=15, mean age 16.75±1.4), Group 2 (30–40; n=17; mean
age 34.4±1.6), and Group 3 (N50 yrs; n=8; mean age 61.33±
7.4). The body mass index (BMI) of volunteers (male and fe-
male) varied from 24 to 29 kg/m2. The ASCs were isolated from ab-
dominal adipose tissue specimens from volunteers using a previously
described method (Izadpanah et al., 2006). Briefly, 50 g of tissue
was minced and digested with collagenase Type I (Invitrogen
Corp., Carlsbad, CA, USA) for 60min at 37 °C. Following this, they
were subject to RBC lysis buffer (BioWhittaker, Walkersville, MD,
USA). The cells were plated at a fixed density in alpha-MEMmedium,
supplemented with 20% fetal bovine serum (Atlanta Biologi-
cal, Atlanta, GA), 1% L-Glutamine, and 1% Penicillin/Strepto-
mycin (Cellgro, Herndon, VA, USA) at 37 °C with a 5% CO2
atmosphere. Upon reaching 70% confluency, the cells were
passaged further.
Quantitative real time PCR analysis
Using an RNA isolation kit total cellular RNA was isolated
from cell cultures of all three groups and the multi-lineage
differentiated cells (GE lifesciences, Piscataway, NJ, USA).
From here the cDNAwas generated using High Capacity Reverse
Transcription Kit (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer's instructions.
Assay for colony forming unit (CFU) and population
doubling time (DT)
ASCs from the three groups were plated at densities of 1000,
500, 250, 100, 50 and 25 cells/cm2 in 12-well dishes. Cells
were cultured for ten (10) days before they were fixed and
stained with 1% crystal violet in methanol. Colonies with
diameters larger than 3 mm were considered for counting.
For doubling time experiments, 20,000 ASCs from the
three groups were plated in a 75 cm2 flask and counted at
48, 72 and 96 hour time points. The population doubling
time for each time point was calculated using the formula:
DT=n× log10 (2n/m)/log10 t; where, n=number of cells at the
beginning of the time period, m=number of cells counted
at the end and t=time period. Thus the doubling time was
ascertained from at least 3 time points and the mean was
calculated accordingly.
Flow cytometry and cell cycle analysis
Flow cytometry was performed on trypsin-dissociated ASC
cultures stained for CD105, CD90, CD44, CD146, CD34, CD45,CD4, and CD11b (Invitrogen Corp., Carlsbad, CA, USA) on a
Beckman-Coulter Epics FC500 flow cytometer.
For analysis of cellular DNA content, cultured cells at the
confluency of ~70–75% were fixed in 70% ethanol, rehydrated
in PBS, treated for 30 min with RNase A (1 mg/mL), and
stained with 1 μg/mL of propidium iodide (PI) for 5 min. The
fluorescence intensity was determined using a fluorescent-
activated cell sorter (FACS) and the percentage of cells in
different phases of cell cycle was assessed.
Multi-lineage differentiation
Adipogenic differentiation was determined in cultures of ASCs
from all three groups using previously described methods
(Izadpanah et al., 2006). Adipogenic potentials were evaluated
by oil red O staining and real time PCR analyses of lineage-
specific genes (Diagnostic BioSystems, Pleasanton, CA).
Osteogenic differentiation was induced as previously
described (Izadpanah et al., 2005). Differentiated cells
were either fixed and stained with Alizarin Red (Diagnostic
BioSystems) or quantified for alkaline phosphatase activity
(ALP) using the SensoLyte™ pNPP Alkaline Phosphatase Assay
Kit (AnaSpec, San Jose, CA, USA). All analyses were carried
out in triplicate.
Chondrogenic differentiation was accomplished by using
the Stempro® chondrogenesis differentiation kit (Invitrogen
Corp., Carlsbad, CA, USA). About 1×105 cells were spun in a
15 mL conical tube and grown in chondrogenic media for
21 days. Micro masses were fixed and stained with toluidine
blue.
Multi-lineage potential was also evaluated by real time
PCR analyses for expression of lineage-specific genes.
Quantitative real time PCR analysis
Total cellular RNA was isolated from ASCs of different age
groups using an RNeasy mini kit (Qiagen, Valencia, CA,
USA). cDNA was obtained by using the High Capacity Reverse
Transcription Kit (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer's instructions. The following
primers were used: GAPDH 5′-CGAGATCCCTCCAAAATCAA-3′
and 5′-GGTGCTAAGCAGTTGGTGGT-3′; TRAF 5′-CAGAGGTTGT
GCAGAGCAGT-3′ and 5′-CCGGTATTTACACGCCTTCT-3′; BIRC5
5′-TCCCTGGCTCCTCTACTGTT-3′ and 5′-TGTCTCCTCATCCACC
TGAA-3′; hTERT 5′-GGAGCAAGTTGCAAAGCATTG-3′ and 5′-
TCCCACGACGTAGTCCATGTT-3′; NFκB 5′-GAAGCTGAAGTG
CATCCAAA3′ and 5′-GGGACAACAGCAATGACAAC3′; RB1 5′-
AAAGGACCGAGAAGGACCAA-3′ and 5′-CTGGGTGCTCAGACA
GAAGG-3′; ATM 5′-ACTGCCAAGGACAAATGAGG-3′ and 5′-TGA
GCAACTGACTGGCAAAC-3′; BAX 5′-GCTGGACATTGGACTTCC
TC-3′ and 5′-CTCAGCCCATCTTCTTCCAG-3′; CHEK1 5′-AGCG
GTTGGTCAAAAGAATG-3′ and 5′-CCCTTAGAAAGCCGGAAGTC-
3′; TNFα 5′-CTGCTGCACTTTGGAGTGAT-3′ and 5′-GGACCTGG
GAGTAGATGAGG-3′; E2F4 5′-GAGCCCATCTGCTGTTTCTA-3′
and 5′-CTGAGCTCACCACTGTCCTT-3′; APEX 5′-TGTGTGGA
GACCTCAATGTG-3′ and 5′-GTAGGCATAGGGTGTGTTGG-3′;
ATR 5′-GAATCACGACTCGCTGAACT-3′ and 5′-TCGGCCCACTAG
TAGCATAG-3′; Caspase3 5′-CCCCTGGATCTACCAGCATA-3′
and 5′-TGTCTCTGCTCAGGCTCAAA-3′; Caspase8 5′-AACCTCG
GGGATACTGTCTG-3′ and 5′-CCTGTCCATCAGTGCCATAG-3′;
p53 5′-TCTACCTCCCGCCATAAAA-3′ and 5′-CTCCTCCCCACAA
223Aging alters tissue resident mesenchymal stem cell propertiesCAAAAC-3′; BCL2 5′-AGATGGGAACACTGGTGGAG-3′ and 5′-
CTTCCCCAAAAGAAATGCAA-3′; Leptin 5′-GAAGGTCACTCTTCC
TGCAA-3′ and 5′-TTGGTTTCAAGCAAAAGGAG-3′; CEBPA 5′-
CTAGGAACACGAAGCACGAT-3′ and 5′-ATGGTGGTTTAGCAGA
GACG-3′; BMP-6 5′-AACCTGGTGGAGTACGACAA-3′ and 5′-
CGGGTGTCCAACAAAAATAG-3′; COL2A1 5′-TCACGTACACTGC
CCTGAAG-3′ and 5′-TGCAACGGATTGTGTTGTTT-3′; COL10A1
5′-CTGGGACCCCTCTTGTTAGT-3′ and 5′-TTCCAGTCCTTGGGT
CATAA-3′; (Realtimeprimers.com, Elkins Park, PA). All reac-
tions were run at 58 °C using a Bio-Rad iCycler (Bio-Rad Labo-
ratories, Hercules, CA).
Real-time PCR assays
Real-time PCR assay was performed with 200 ng of target
DNA (extracted from homogenized frozen tissues) and Alu-
specific primers. Values for the amount of target DNA in
each sample were corrected by assays for the single-copy
mouse albumin gene (Lee et al., 2006b).
Telomerase assay
Telomerase activity was measured using a TRAPeze® ELISA
Telomerase Detection Kit (Millipore, MA, USA) according to
the standard telomeric repeat amplification protocol
(TRAP) based on a previously published method (Kim and
Wu, 1997).
Comet assay
The comet assay was performed on ASCs from different age
groups according to manufacturer's protocols (Cell Biolabs
Inc. San Diego, CA, USA). Briefly, electrophoresis was carried
out on 1×105 cells layered on comet slides for 30 min at 25 V
and 300 mA. Then the slides were stained with 100 μL/well
of diluted Vista Green DNA Dye (Cell Biolabs Inc. San
Diego, CA, USA). Three slides were prepared for each cell
population/age group and from each slide 50 cells were
evaluated. Comet tail lengths and tailmomentsweremeasured
with a computer aided image analysis system (CASP software,
download in http://casp.sourceforge.net/ index.Php).
miRNA analysis
miRNA from ASCs of all three groups was isolated from the
corresponding cell pellets. Subsequently a miRNA array
using hybridization technique was employed to evaluate
the expression level of miRNA within each cell line. miRNA
microarrays were designed per deoxyoligonucleotide arrays
(Miltenyi Biotech, Auburn, CA, USA) and hybridized using
standard conditions. Samples and a synthetic pool of 816
oligo ribonucleotides were separately fluorescent labeled
using miRCURY LNA microRNA Array labeling kit (Exiqon,
Vedbaek, Denmark). miRNA expression was then compared
between Groups 1 and 3. miRNAs containing at least two
copies in at least three samples per group were used to in-
vestigate the correlation in expression of miRNAs between
the groups. miRNAs whose expression changed by more
than 1 SD between Groups 3 and 1 and show at least 1.5
fold change were selected.For validation of the miRNA array we selected a number
of miRNAs that showed significant changes in Group 3 versus
Group 1 for RT-PCR based miRNA detection. Following isola-
tion of RNA, cDNA was generated using RT2 cDNA synthesis
kit according to the manufacturer's protocol (Exiqon, Vedbaek,
Denmark). The miRNA-qRT-PCR was then used to analyze
selected miRNAs using SYBRgreen MasterMix (Exiqon, Vedbaek,
Denmark). Relative expression levels were calculated based on
the expression of three constitutive (u6, 5s, snord44) miRNA
references. Expression levels of miRNAs were calculated after
subtracting the CT-values of the endogenous references, and
fold change of gene expression was subsequently calculated
using ΔΔCT-method. The primers used for microRNA PCR were
mir-let 7g: UGAGGUAGUAGUUUGUACAGUU, mi-27b: UUCACA
GUGGCUAAGUUCUGC, mi-106a: AAAAGUGCUUACAGUGCAG
GUAG, and mi-199a: CCCAGUGUUCAGACUACCUGUUC.
In vivo tumorigenicity
Immune-deficient NIHIII 6-week-old mice were inoculated
subcutaneously with 1×106 cells (200 μL of PBS) obtained
from all three groups in (9 mice per group; n=3 volunteers/
group). 200 μL of plain PBS was injected in one group of animal
as negative control. One group of animals was injected with
1×106 MDA-MB231 cells, which is a transformed breast carcino-
ma cell line as a positive control. All animals weremaintained in
specific pathogen-free conditions, and all experiments
conformed to the requirements of the Animal Welfare Act
and the Institutional Animal Care and Use Committee.
Statistical methodology
All data relating to study specific were summarized using
descriptive statistics such as mean, standard deviation. The
variance method was used to compare the mean differences.
Where meaningful, the results were presented graphically.
The study hypotheses were tested at 5% level of significance
throughout the analysis. Estimates of means and their 95%
confidence intervals were calculated. R-computing software
was used to plot the graphs.
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